Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ: CMPS )

5.980 +0.170 (+2.93%)
Streaming Delayed Price Updated: 3:17 PM EDT, Jun 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
27 28 Next >
2 Potentially Explosive Growth Stocks Down 30% or More to Buy for the Next Bull Market
Investing now is an admittedly risky bet, but the payoff could be massive. 
Via The Motley Fool
2 Growth Stocks With Incredible Potential in the Next 5 Years
Neither is profitable, but both could be on the verge of massive booms in revenue. 
Via The Motley Fool
Cybin, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From March 2, 2023
Via Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2023
Via Benzinga
Earnings Preview: Compass Pathways
Via Benzinga
COMPASS Pathways Shares Q4 & Year-End 2022 Financials, Advances Phase 3 Psilocybin Trials
Mental healthcare biotech COMPASS Pathways (NASDAQ: CMPS) reported its financial results for the fourth quarter and year-end 2022 and provided an update on recent pipeline and business progress.... 
Via Benzinga
Compass Pathways Plc (CMPS) Q4 2022 Earnings Call Transcript
CMPS earnings call for the period ending December 31, 2022. 
Via The Motley Fool
COMPASS Pathways Announces Fourth Quarter and Year-End 2022 Financial Results and Business Highlights
From COMPASS Pathways
Via GlobeNewswire
Psychedelic Stock Gainers And Losers From February 27, 2023
Via Benzinga
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage... 
Via Talk Markets
Psychedelic Stock Gainers And Losers From February 24, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 23, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 21, 2023
Via Benzinga
Psychedelic Stock Gainers And Losers From February 20, 2023
Via Benzinga
John Oliver's Take On Psychedelic Assisted Therapy: There's Huge Potential If Done Responsibly
John Oliver is back on "Last Week Tonight" and is once again taking a deep dive into a very intriguing topic: the potential benefits of psychedelic-assisted therapy. The show, which aired on Sunday,... 
Via Benzinga
"Rags-To-Riches" Portfolio Underperforming YTD
The munKNEE 
Via Talk Markets
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD
A look at the performance of the six largest psychedelic stocks by market capitalization. 
Via Talk Markets
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2023
Via Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
Via Benzinga
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
10 Short Squeeze Candidates To Watch This Week: Getty, Lannett, AirSculpt And More
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
Via Benzinga
7 Long-Term Stocks to Buy With Your Tax Refund
Although you might want to spend your tax refund, a better approach is to target compelling long-term stocks to buy. 
Via InvestorPlace
Major Psychedelic Compound-Based Stocks UP 13% YTD
We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances. 
Via Talk Markets
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.